Comment on: Zhu et al. Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus: New Evidence From China. Diabetes Care 2013;36:2038–2040

نویسندگان

  • Charles Savona-Ventura
  • Josanne Vassallo
  • Michel Marre
  • Basil G. Karamanos
چکیده

The article by Zhu et al. (1) published inDiabetes Care concludes that a fasting plasma glucose (FPG) at 24–28 weeks’ gestation can be used in lowresource regions as a screening test to identify gestational diabetes mellitus (GDM) in Chinese patients. However, in their experience, a screening protocol using FPG cutoff points of $4.4 and #5.0 mmol/L would fail to identify about 12% of the GDM cases and require a formal oral glucose tolerance test (OGTT) to be performed in about half of the pregnant population (1). These observations contrast with our findings in a circum-Mediterranean population (2). In our population, a comparative FPG screening protocol followed by an OGTT in those women whose FPG level was 4.4–5.0 mmol/L will fail to identify 10.1% of the GDM population as defined by the American Diabetes Association criteria but would require a formal OGTT in 31.1% of the pregnant population. In our experience, a further reduction in the number of OGTT tests can be obtained by using a composite risk criteria whereby women with an FPG $5.1 mmol/L are considered as suffering from GDM in line with the International Association of the Diabetes and Pregnancy Study Groups criteria of diagnosis (accounting for 73.9% of GDM cases and 9.8% of normal glucose tolerance [NGT] women);womenwith anFPG#4.4mmol/L are considered as normal (accounting for 10.1% of GDM cases, 57.7% of NGT cases); and women with FPG values of 4.4–5.0 mmol/L are considered as suffering from GDM if they are adipose (defined as a prepregnancy BMI ,25 kg/m or a third trimester BMI ,30 kg/m) accounting for 5.9% of the GDM cases and 14.2% of the NGTwomen. AnOGTTwould then only be required in lean women whose FPG screening test was 4.4–5.0 mmol/L who account for only 17.6% of the population. This composite screening protocol using an FPG, maternal adiposity, and targeted OGTT has a sensitivity and specificity of 89.9 and 76.1%, and positive and negative predictive values of 26.4 and 1.2%. This composite screening is similarly useful should one prefer to adopt the International Association of the Diabetes and Pregnancy Study Groups criteria for diagnosis. In this situation, the protocol had a sensitivity and specificity of 84.1 and 86.3%, and positive and negative predictive values of 68.9 and 6.3%. It does appear therefore that in the Mediterranean population, it is reasonable to adopt a composite screening protocol to identify GDMwomen, especially when one considers that the adipose pregnant NGT woman carried similar risks and should receive similar lifestyle and nutritional advice as the GDM woman.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Response to Comment on: Zhu et al. Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus: New Evidence From China. Diabetes Care 2013;36:2038–2040

A s mentioned in the letter by SavonaVentura et al. (1), the results of fasting plasma glucose (FPG) screening protocol followed by an oral glucose tolerance test (OGTT) in the pregnant women whose FPG level was 4.4–5.0 mmol/L show a similar trend in the rate of missed diagnosis (12.2 vs. 10.1%) between our study (2) and their study (3), but substantially diverse rate in requiring a formal OGTT...

متن کامل

Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus

OBJECTIVE To evaluate the usefulness of a fasting plasma glucose (FPG) at 24-28 weeks' gestation to screen for gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS The medical records and results of a 75-g 2-h oral glucose tolerance test (OGTT) of 24,854 pregnant women without known pre-GDM attending prenatal clinics in 15 hospitals in China were examined. RESULTS FPG cutoff val...

متن کامل

Evaluation of the Value of Fasting Plasma Glucose in the First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China

OBJECTIVE To evaluate the value of fasting plasma glucose (FPG) value in the first prenatal visit to diagnose gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS Medical records of 17,186 pregnant women attending prenatal clinics in 13 hospitals in China, including the Peking University First Hospital (PUFH), were examined. Patients with pre-GDM were excluded; data for FPG at the...

متن کامل

Response to Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332-337.

The comment by Barbour and Davies (1) acknowledges that our study (2) is important given the increasing popularity of oral agents to treat gestational diabetes mellitus (GDM)but raises concernswhether the study design and conclusions can be generalized to other GDM populations. With regard to treatment efficacy before 24 weeks, in our study the success rate of oral treatments before and after 2...

متن کامل

Issues With the Diagnosis and Classification of Hyperglycemia in Early Pregnancy.

In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) panel published consensus-based recommendations on the diagnosis and classification of hyperglycemia in pregnancy (1). Within that document, the recommendations regarding early pregnancy testing were designed to facilitate early detection and treatment of hyperglycemia (HbA1c $6.5% [48 mmol/mol], fasting ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 36  شماره 

صفحات  -

تاریخ انتشار 2013